CD68 and non-small cell lung carcinoma: Since CD68 TAMs in the tumoural microenvironment are influenced by hypoxia, [18F]-FDG PET has demonstrated its capacity to predict hypoxia in vivo with a positive correlation between SUV and CD68 positive staining, as reported in 98 matched NSCLC specimens [94].